Cite
Nishikawa T, Watanabe R, Kitano Y, et al. Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas. Brain Tumor Pathol. 2021;39(1):14-24doi: 10.1007/s10014-021-00418-x.
Nishikawa, T., Watanabe, R., Kitano, Y., Yamamichi, A., Motomura, K., Ohka, F., Aoki, K., Hirano, M., Kato, A., Yamaguchi, J., Maeda, S., Kibe, Y., Saito, R., Wakabayashi, T., Kato, Y., Sato, S., Ogino, T., Natsume, A., & Ito, I. (2022). Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas. Brain tumor pathology, 39(1), 14-24. https://doi.org/10.1007/s10014-021-00418-x
Nishikawa, Tomohide, et al. "Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas." Brain tumor pathology vol. 39,1 (2022): 14-24. doi: https://doi.org/10.1007/s10014-021-00418-x
Nishikawa T, Watanabe R, Kitano Y, Yamamichi A, Motomura K, Ohka F, Aoki K, Hirano M, Kato A, Yamaguchi J, Maeda S, Kibe Y, Saito R, Wakabayashi T, Kato Y, Sato S, Ogino T, Natsume A, Ito I. Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas. Brain Tumor Pathol. 2022 Jan;39(1):14-24. doi: 10.1007/s10014-021-00418-x. Epub 2021 Nov 26. PMID: 34826036.
Copy
Download .nbib